The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development and validation of a clinical risk score for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO Resect group.
 
Philipp Karschnia
No Relationships to Disclose
 
Jacob S Young
No Relationships to Disclose
 
Antonio Dono
No Relationships to Disclose
 
Levin Häni
No Relationships to Disclose
 
Stephanie T. Jünger
No Relationships to Disclose
 
Tommaso Sciortino
No Relationships to Disclose
 
Nico Teske
No Relationships to Disclose
 
Gilbert Youssef
No Relationships to Disclose
 
Francesco Bruno
No Relationships to Disclose
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Consulting or Advisory Role - Midatech Pharma; Olympus; SERVIER
Research Funding - Celgene (Inst); Denovo Biopharma (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patent for drug delivery devices, assigned to Moffitt Cancer Center.; Patents for drug delivery devices for the brain
 
Roberta Rudà
Consulting or Advisory Role - Bayer; Genenta Science; Novocure; Servier; UCB
 
Raymond Yi-kun Huang
Consulting or Advisory Role - Agios; Nuvation Bio; Nuvation Bio; Vysioneer
Research Funding - Agios; Bristol-Meyers-Squibb
 
Patrick Y. Wen
Consulting or Advisory Role - Anheart Therapeutics; AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Celularity; Chimerix; Day One Biopharmaceuticals; Genenta Science; GlaxoSmithKline; Insightec; Kintara Therapeutics; Merck; Mundipharma; Mundipharma; Novartis; Novocure; Novocure; Prelude Therapeutics; Prelude Therapeutics; Sagimet Biosciences; Sapience Therapeutics; Servier; Servier; SymBio Pharmaceuticals; Tango Therapeutics; Telix Pharmaceuticals; VBI Vaccines
Research Funding - AstraZeneca (Inst); Bayer (Inst); Black Damond (Inst); Chimerix (Inst); Erasca, Inc (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Quadriga Biosciences (Inst); Servier (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Lorenzo Bello
No Relationships to Disclose
 
Stefan J. Grau
No Relationships to Disclose
 
Oliver Schnell
No Relationships to Disclose
 
Yoshua Esquenazi
No Relationships to Disclose
 
Susan Marina Chang
No Relationships to Disclose
 
Mitchel S. Berger
No Relationships to Disclose
 
Joerg Tonn
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis
Research Funding - Munich Surgical Imaging; Novocure
Patents, Royalties, Other Intellectual Property - Springer Publisher